Challenges – Dianosic has been selected among the 100 most innovative startups to invest in 2021


Dianosic has been selected by Challenges magazine as one of the 100 innovative startups where it is worth to invest in 2021 ! Learn more : “Dianosic : innovations disruptives pour les affections ORL”

Share this article

Discover our other articles

Discover the article: Dianosic plans to raise EUR 10m in Series A; to seek exit sale around 2026 – CEO
  Dianosic raises €4.7M to bring treatment for chronic rhinitis into clinical trial. ▶︎ Click here to discover the press release.   Pr. Christian…
  Dianosic laureate of the i-Lab 2019 innovation contest The jury of the prestigious “i-Lab” innovation contest, organized by the Ministère de l’Enseignement Supérieur…